intrapleural photodynamic therapy among patients carrying a malignant pleural mesothelioma

Study controls feasibility of an intrapleural photodynamic therapy integrated into a multimode treatment associating a pleurectomy/extended hulling, a radiotherapy and an auxiliary chemotherapy among patients carrying a malignant pleural mesothelioma. - MesoPDT

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2015-001554-15-FR

Enrollment

Registered

2015-07-23

Start date

2015-08-13

Completion date

Unknown

Last updated

2018-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant pleural mesothelioma

Interventions

Trade Name: Photofrin Product Name: Photofrin Pharmaceutical Form: Powder for injection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Please see French section Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 3 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 3

Exclusion criteria

Exclusion criteria: Please see French section

Design outcomes

Primary

Measure	Time frame
Main Objective: Please see French section ;Secondary Objective: Please see French section ;Primary end point(s): Please see French section ;Timepoint(s) of evaluation of this end point: Please see French section	—

Secondary

Measure	Time frame
Secondary end point(s): Please see French section ;Timepoint(s) of evaluation of this end point: Please see French section	—

Countries

France

Contacts

Public ContactCreton Mélanie

Fédération de Recherche Clinique

melanie.creton@chru-lille.fr

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026